Mobile Health Tool Helps Improve Quality of Life For Young Breast Cancer Survivors - Top-Institutions - MDSpire

Mobile Health Tool Helps Improve Quality of Life For Young Breast Cancer Survivors

dolescent and young adult breast cancer survivors who used a novel mobile health (mHealth) intervention to self-manage post-treatment symptoms and concerns were able to improve their quality of life and reduce the burden of common symptoms compared to patients who received usual care, according to results from a new clinical trial being reported at the 2025 San Antonio Breast Cancer Symposium (SABCS).

  • By

  • December 12, 2025

  • 5 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Oncology
    • Adolescent and Young Adult Oncology
    • Digital Health
    • Survivorship Care

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Oncology
    • Adolescent and Young Adult Oncology
    • Survivorship Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Oncology
    • Adolescent and Young Adult Oncology
    • Digital Health
    • Survivorship Care

  • #4

    Seattle Cancer Care Alliance / Fred Hutchinson Cancer Research Center
    Seattle Cancer Care Alliance / Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Breast Oncology
    • Adolescent and Young Adult Oncology
    • Survivorship Research

Original Source(s)

Mobile Health Tool Helps Improve Quality of Life For Young Breast Cancer Survivors

  • by

  • December 12, 2025

Related Content

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer